Skip to main content
. 2021 Jul 8;22:437. doi: 10.1186/s13063-021-05407-1

Fig. 1.

Fig. 1

Flow diagram of study design. OS, overall survival; PFS, progression-free survival; ORR, objective response rate; ECOG-PS, Eastern Cooperative Oncology Group performance status; FACT-L, Functional Assessment of Cancer Therapy-lung carcinoma; CT, chemotherapy; TCM, traditional Chinese medicine